Heart Attack Diagnostic Market Innovations, Key Trends, and Market Share Analysis Highlight Significant Growth and Demand Forecast

The new report published by The Business Research Company, titled "Heart Attack Diagnostic Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the heart attack diagnostic market size has grown strongly in recent years. It will grow from $10.21 billion in 2023 to $11.07 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $15.26 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=8498&type=smp

Surge In Cardiovascular Disorders Drives Growth In Heart Attack Diagnostics Market
The rising prevalence of cardiac disorders is propelling the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of disorders of the heart and blood vessels affecting the heart. Unhealthy eating, inactivity, usage of tobacco products, and abusing alcohol are the main factors for heart disease and stroke. Heart attack diagnosis helps in analyzing the causes and severity of heart attack, stroke, and heart failure. For instance, a World Health Organization (WHO) study from 2021 estimated that 17.9 million people worldwide died from cardiovascular diseases (CVDs), accounting for 32% of all deaths and 85% of these deaths were due to heart attacks and strokes. This shows the number of people getting cardiovascular disease (CVD) is steadily rising, including one-third of all deaths globally. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics market.

Advancements In Artificial Intelligence Transforming The Landscape
The development of novel diagnostic techniques for heart disease is a key trend in the heart diagnostic market. Major players are developing novel technologies such as artificial intelligence for heart disease diagnosis. Artificial intelligence (AI) is the emulation of human intellect in devices that have been designed to behave and think like humans. AI is utilized to improve the skills of diagnostic radiography, diagnose heart problems, and treat strokes more quickly. For instance, in February 2022, Physician-scientists at the Smidt Heart Institute at Cedars-Sinai, a nonprofit academic healthcare organization, developed an AI-based method to identify hard-to-diagnose cardiac conditions. The AI program can identify illness patterns that are invisible to the human eye and utilize these patterns to forecast the correct diagnosis. Hypertrophic cardiomyopathy and cardiac amyloidosis disorders, which can both be fatal, are efficiently recognized and distinguished by artificial intelligence (AI) technology.

The heart attack diagnostic market covered in this report is segmented -

1) By Test Type: Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=8498&type=discount

Major companies operating in the heart attack diagnostic market report are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., Astrazenca PLC., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc., Beckman Coulter Inc., Schiller AG, GE Healthcare, HeartFlow, Medtronic plc, Cardio Diagnostics Holdings Inc., Beckman Coulter Inc., Becton Dickinson and Company, Danaher Corporation, Edwards Lifesciences Corporation, Illumina Inc., Johnson & Johnson, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific Inc.

Contents of the report:
1. Executive Summary
2. Heart Attack Diagnostic Market Report Structure
3. Heart Attack Diagnostic Market Trends And Strategies
4. Heart Attack Diagnostic Market - Macro Economic Scenario
5. Heart Attack Diagnostic Market Size And Growth
…..
27. Heart Attack Diagnostic Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.